Who owns KIORA PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Kiora Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Kiora Pharmaceuticals stock

Who bought or sold KIORA PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
ADAR1 Capital Management 168k $324k 0% Mar 2026
 View chart
Stonepine Capital Management 131k $258k -7% Dec 2025
 View chart
Citadel Advisors 50k $96k 121% Mar 2026
 View chart
Geode Capital Management 48k $92k 117% Mar 2026
 View chart
Vanguard Group 33k $65k 58% Dec 2025
 View chart
Renaissance Technologies 21k $42k 71% Dec 2025
 View chart
Vanguard Capital Management 20k $38k 100% Mar 2026
 View chart
Vanguard Fiduciary Trust 13k $25k 100% Mar 2026
 View chart
Two Sigma Securities 12k $23k 100% Mar 2026
 View chart
XTX Topco 12k $24k 100% Dec 2025
 View chart
Rangeley Capital 10k $19k 100% Mar 2026
 View chart
Tower Research Capital 1.6k $3.1k 100% Dec 2025
 View chart
Morgan Stanley 1.4k $2.7k 100% Mar 2026
 View chart
UBS Group 1.3k $2.5k 43% Mar 2026
 View chart
SBI Securities 256.00 $494.003200 0% Mar 2026
 View chart
Vanguard Global Advisers 200.00 $386.000000 100% Mar 2026
 View chart
BlackRock 58.00 $111.998000 0% Mar 2026
 View chart
Caitong International Asset Management 6.00 $12.000000 100% Mar 2026
 View chart
Activest Wealth Management 2.00 $4.000000 0% Mar 2026
 View chart
Advisor Group Holdings 2.00 $3.000000 0% Dec 2025
 View chart

Who sold out of Kiora Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
DRW Holdings Dec 2025 110k $217k
Nantahala Capital Management Dec 2025 106k $209k
Alyeska Investment Group Dec 2025 77k $152k
Miller Wealth Advisors Dec 2025 1.0k $2.0k
Goss Wealth Management Dec 2025 22.00 $42.999000